Companies by Subsector - Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| VAL | ValiRx | AIM | £1.91M | 0.14 | -2.20% | |
| PRM | Proteome Sciences | AIM | £4.91M | 1.45 | 8.00% | |
| VRCI | Verici Dx | AIM | £5.15M | 0.20 | -4.80% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| OPTI | OptiBiotix Health | AIM | £6.56M | 6.42 | -3.30% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| OBD | Oxford BioDynamics | AIM | £15.46M | 0.11 | -4.00% | |
| IXI | Ixico | AIM | £16.35M | 7.00 | -1.50% | |
| EDEN | Eden Research | AIM | £17.27M | 2.30 | -2.40% | |
| GDR | Genedrive | AIM | £20.47M | 1.25 | -1.60% | |
| IMM | ImmuPharma | AIM | £21.84M | 3.20 | -3.00% | |
| SBTX | SkinBioTherapeutics | AIM | £23.97M | 9.00 | -14.90% | |
| AREC | Arecor Therapeutics | AIM | £30.58M | 81.00 | -1.30% | |
| HVO | Hvivo | AIM | £43.97M | 6.10 | -5.10% | |
| ABDX | Abingdon Health | AIM | £47.86M | 10.68 | 2.60% | |
| ANIC | Agronomics | AIM | £53.09M | 4.90 | -0.60% | |
| OBI | Ondine Biomedical Inc | AIM | £53.25M | 10.75 | 2.60% | |
| FARN | Faron Pharmaceuticals OY | AIM | £72.29M | 35.00 | 1.10% | |
| 4BB | 4basebio | AIM | £74.58M | 502.21 | -0.40% | |
| BVXP | Bioventix | AIM | 8.78 | £78.9M | 1,500.00 | -2.20% |
| ANP | Anpario | AIM | 2.65 | £92.05M | 459.90 | -0.90% |
| SCLP | Scancell Holdings | AIM | £120.62M | 9.89 | -1.10% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| DXRX | Diaceutics | AIM | £135.81M | 162.75 | -0.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BTG | BTG | AIM | 4.18 | £172.67M | 108.50 | -0.10% |
| PRTC | Puretech Health | FTSE Small Cap | £292.74M | 119.80 | 0.34% | |
| AVCT | Avacta Group | AIM | £353.65M | 80.00 | -7.00% | |
| GNS | Genus | FTSE 250 | 1.63 | £1.42B | 2,150.00 | 0.75% |